Cytokinetics Stock News

SOUTH SAN FRANCISCO, Calif., July 16, 2020 -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced the pricing of an underwritten public offering of 7,291,667 shares of its.

So far Thursday, July 16, NASDAQ is up 1.64% and the S&P is up 0.59%. Let’s take a look at

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) * Atossa Therapeutics Inc (NASDAQ: ATOS) (announced r

Cytokinetics, Inc. (NASDAQ:CYTK) Director Sandford D. Smith sold 6,667 shares of the stock in a transaction dated Friday, July 10th. The stock was sold at an average price of $28.00, for a total trans

SOUTH SAN FRANCISCO, Calif., July 15, 2020 -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced plans to offer, subject to market and other conditions, $150,000,000 of.

Topline Results from GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil, Cardiac Myosin Activator, Expected in Q4 Licensing Collaboration and Royalty Monetization.

Needham analyst Chad Messer assigned a Buy rating to Cytokinetics (CYTK – Research Report) today and set a price target

$250 Million in Committed Capital to Cytokinetics; Additional $200 Million in Development and Commercialization Milestone PaymentsJi Xing Pharmaceuticals to Develop & Commercialize in China RTW Provi

RTW Investments, LP, (“RTW”) is pleased to announce Ji Xing Pharmaceuticals (“Ji Xing”), a biotechnology company based in Shanghai and backed by RTW,

SOUTH SAN FRANCISCO, Calif., July 13, 2020 -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is participating in the launch of Kainomyx, Inc., a new.

Equities researchers at Raymond James assumed coverage on shares of Cytokinetics (NASDAQ:CYTK) in a report issued on Friday, MarketBeat.com reports. The firm set a “strong-buy” rating and a $39.00

AQR Capital Management LLC increased its holdings in Cytokinetics, Inc. (NASDAQ:CYTK) by 7.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Co

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday

So far Friday, July 10, NASDAQ is up 0.69% and the S&P is up 1.94%. Here are this morning’s most

Upgrades * For Triumph Bancorp Inc (NASDAQ: TBK), DA Davidson upgraded the stock from Neutral to Buy. Triumph Bancorp earned ($0.18) in the first quarter, compared to $0.55 in the year-ago quarter.